Frequently Asked Questions

 Annual General Meeting FAQsView PDF  

COVID-19 is an infection caused by a type of coronavirus. It primarily spreads through saliva droplets, similar to how the common cold and seasonal flu are transmitted. COVID-19 appears to be more contagious than the seasonal flu, with an infection rate 1.5 to 2 times higher. Fortunately, most people who contract COVID-19 experience only mild symptoms, such as fever, cough, and shortness of breath.

The primary symptoms include:

  • Fever
  • Cough
  • Shortness of breath or difficulty breathing

COVID-19 spreads quickly, through:

  • Coughing or sneezing - If you are within one metre of someone who is infected, you may breathe in droplets expelled by their coughs or exhalations.
  • Close personal contact - Activities such as shaking hands or touching others can transmit the virus
  • Touching - The virus can be present on objects like desks, tables, or telephones after being coughed or breathed on by an infected person. If you then touch your mouth, nose, or eyes before washing your hands, you risk infection.

Healthcare Professionals can only treat the symptoms of COVID-19 as they present. No specific therapy is effective against the virus itself. If you meet any of the criteria listed below, you must seek medical care early and inform your Healthcare Professional of your recent travel history.

When to seek medical care:

  • If you have acute respiratory illness and suddenly have a cough, sore throat, shortness of breath or fever (>= 38°C)
  • Were in close contact with someone who had a probable or confirmed case of COVID-19 infection
  • If you have travelled to areas with presumed ongoing community transmission of COVID-19
  • If you have worked in or attended a health care facility where patients with COVID-19 infections were being treated
  • If you have been admitted with severe pneumonia of unknown aetiology

People who contract COVID-19 may take anywhere from one to 14 days to develop symptoms. Even if you have not recently travelled to a COVID-19-affected region, or had contact with an individual who has been affected by the illness, you must still inform your Healthcare Professional if you meet the criteria listed above. A virtual consultation is an excellent way to consult with your Healthcare Professional.  

During the pandemic, Bankmed's enhanced our COVID-19 basket of care with an additional Hospital at Home Benefit. The Hospital at Home Benefit was introduced to assist with capacity constraints and to alleviate pressure from the in-hospital setting for members who could be treated safely at home.

The Hospital at Home Benefit is open to high-risk members who test positive for COVID-19 and are mildly symptomatic and at risk for hospitalisation. Additionally, had these members been admitted, they would have met the criteria for general ward admission, but not High Care or ICU.

The Hospital at Home Benefit consists of two components:

1. Remote Monitoring
Bankmed provides members who require monitoring with daily check-in calls from the remote monitoring system, 24-hour monitoring by the Care team, oversight by the treating Healthcare Professional, and a biosensor patch to remotely monitor vitals and alerts for out of range readings.

1.1 Qualifying criteria:

  • High risk patients >35 years with comorbidities +/- obesity who are COVID-19 positive are symptomatic and at increased risk of hospitalisation

1.2 Criteria for GP vs Physician monitoring:

  • Based on admitting/referring Healthcare Professional for remote monitoring

2. Hospitalisation in the Home
Bankmed provides members with acute in-patient treatment at home to avoid hospitalisation. This benefit also covers members who are deemed medically stable by their treating provider to be discharged from hospital earlier to continue their treatment at home.

2.1 Qualifying criteria:

  • Patients >18 years in Stage 2 COVID-19 infection who meet criteria for hospitalisation

2.2 Criteria for GP vs Physician monitoring:

  • For hospitalisation at home only physicians eligible

How does a member access this benefit?

Contact your Healthcare Professional who will determine whether you qualify for this benefit based on the criteria mentioned above. If you do, they will get in touch with Bankmed to start the preauthorisation process.

For more information call 0800 BANKMED (0800 226 5633) or e-mail enquiries@bankmed.co.za.

Answers to important questions about COVID-19 vaccines

Q: How do we overcome anti-vaccine sentiment and myths around vaccination?

A: It's important that we confront anti-vaccine sentiment - and any misinformation around COVID-19 vaccines - with credible content and well-considered responses. First, the approved vaccines have been developed by big and well-established companies that have been around for decades. They employ thousands of scientists and Healthcare Professionals, and these are the people who have developed the vaccines, giving us a significant sense of the caliber of people who are working on vaccine development.

There are many excellent reasons why these vaccines have been developed so quickly, including unprecedented access to funding, the global priority placed on their development and access to thousands of trial participants. These vaccines have also undergone rigorous testing in every phase of the clinical trial process and been tested across massive groups of participants (up to 60 000 people) once they have reached the phase 3 clinical trial phase. The results of these clinical trials so far demonstrate high levels of efficacy (most well over 90%) and safety.

Keep in mind that COVID-19 vaccines are only approved if two requirements are met:

  • The vaccine is safe
  • The vaccine is effective

South Africa also has a very strong regulator, namely the South Africa Health Product Regulatory Authority (SAPHRA). This regulator is responsible for approving all medication and vaccines for use in South Africa and conducts an in-depth and extensive scientific and analysis of the safety and efficacy clinical data of all medical products before approving their use in South Africa.

Also, getting vaccinated is a far more 'natural' way of preventing disease than taking other pharmaceutical products.

Q: We will have access to a number of different vaccines. Are they all equal in efficacy?

A: All the vaccines that we will have access to in South Africa are required to meet a minimum standard of efficacy to be effective on a population basis. And, the COVID-19 vaccines that have been approved for use are well above these levels of efficacy, at around 90% for most. Where a two-dose vaccine regimen is indicated, people will receive the same vaccine in the first and second round.

Q: How serious are COVID-19 vaccine side effects?

A: We have seen very minor or no side effects in other countries where vaccine rollout process are under way. The most common side effects are some pains around the injection site that last a few hours and resolve within a day, as well as other flu-like side effects that also resolve very quickly and are indicative of the immune response taking place.

The more severe adverse events are extremely rare. In most instances, adverse reactions linked to vaccines are far lower than adverse events linked to taking medicines. As evidence of this, latest statistics indicate just 2.8 severe adverse events per million vaccinations for the Moderna vaccine. This means the likelihood of severe adverse events is extremely low and that they are extremely rare.

There will also be Healthcare Professionals on site at every vaccination centre to immediately manage any potential adverse event that might occur.

Out-of-hospital cover

The WHO Global Outbreak Benefit is available to all members of Bankmed during a declared outbreak period. The benefit covers you for the COVID-19 vaccine as well as a defined basket of care for out-of-hospital healthcare services related to COVID-19.

As part of the basket of care, you are covered for:

  • COVID-19 vaccine and the administration of the vaccine
  • Screening consultations with a Network GP (either virtual consultations, telephone or face-to-face)
  • COVID-19 PCR and Rapid Antigen screening tests (only two tests) if referred by your Healthcare Professional, or if referred by a Network GP
  • A defined basket of pathology tests for COVID-19 positive members
  • A defined basket of X-rays and scans for COVID-19 positive members
  • Supportive treatment, including medication and at-home monitoring device to track oxygen (pulse oximeter) saturation levels for at-risk members who meet the clinical entry criteria

The Hospital at Home Benefit is open to high-risk members who test positive for COVID-19 and are mildly symptomatic and at risk for hospitalisation.

This benefit is available on all Plans and is covered by Bankmed as a Prescribed Minimum Benefit (PMB) without using your day-to-day benefits, where applicable.

Cover is subject to Bankmed's Preferred Providers (where applicable), protocols and the treatment meeting Bankmed's entry criteria and guidelines. Any recommended treatment and healthcare services that are not included in the basket of care may be covered according to the benefits available on your chosen Plan in line with Bankmed Scheme Rules and clinical guidelines or in accordance with Prescribed Minimum Benefits (PMBs), where applicable.

In-hospital treatment

In-hospital treatment related to COVID-19 for approved admissions is covered from the Hospital Benefit based on your chosen Plan and in accordance with Prescribed Minimum Benefits (PMB) where applicable.

Cover for COVID-19 vaccine

The WHO Global Outbreak Benefit is available to all members of Bankmed during a declared outbreak period. The benefit provides cover for the COVID-19 vaccine as well as a defined basket of care for out-of-hospital healthcare services, related to the outbreak disease.

The COVID-19 vaccine and administration of the vaccine are covered as Prescribed Minimum Benefits (PMB) without using your day-to-day benefits.

Bankmed members on all Plan types are covered for COVID-19 test. The cost of the test is covered from the Insured Benefits (Risk), as long as the test meets the National Institute for Communicable Diseases (NICD) protocol and you're referred by a Healthcare Professional. You are covered for the test whether the result is negative or positive.

You are also covered for a COVID-19 test if you've received authorisation to go to hospital, as long as a Healthcare Professional refers you.

COVID-19 is diagnosed by taking a sample from your respiratory tract - either your nose, throat or chest.

If you have symptoms of COVID-19 or you may have been exposed to a COVID-19 infection, you need to consult with a Healthcare Professional. If necessary, they will refer you for testing. Call your Healthcare Professional or book a virtual consultation rather than going to their consulting rooms first. Online Healthcare Professional consultations provide a safe alternative to face-to-face consultations for patients and doctors.

The following information provides simple guidelines for members needing an ambulance or hospital admission for COVID-19:

  1. If you require an ambulance, call 0860 999 911, and Netcare 911 will assist you.
  2. Netcare 911 will dispatch a response vehicle to assess your vital signs. Based on the assessment, they will transport you to a casualty unit if necessary.
  3. If hospital admission is required, Netcare 911 will coordinate bed availability through the Joint Operation Centre (JOC), which is connected to all main hospitals.
  4. If possible, you may choose to drive yourself to the nearest casualty unit instead of waiting for an ambulance.
  5. Only go to a casualty unit if you are experiencing difficulty breathing or can monitor signs that indicate your condition is worsening. If you have flu-like symptoms, contact your Healthcare Professional.
  6. If your Healthcare Professional determines that admission is necessary, a hospital bed will be arranged. Members may also be transferred to facilities outside their province if required.
 2026 Basic Plan FAQsView PDF  
 2026 Essential Plan FAQsView PDF  
 2026 Core Saver Plan FAQsView PDF  
 2026 Comprehensive Plan FAQs View PDF  
 2026 Plus Plan FAQsView PDF  
 2026 Traditional Plan FAQsView PDF  

 Bankmed Tax FAQsView PDF  
 Finding a Healthcare Professional or Network HospitalView PDF